Allied-Market-Research-mobile

Coming Up With New Logo

Cart
0
Get 20% Free Customization In This Report

Smart Inhalers Market by Product [Inhalers (Dry Powder Inhalers, Metered Dose Inhalers) and Nebulizers], Indication (Asthma and COPD), End User (Patients and R&D) - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • ID: LI 161715
  • Sep 2016
  • 202 pages
  • Price: $4296
$2765

Smart Inhalers Market Overview:

Global Smart Inhalers Market is estimated to reach $191 million by 2022, growing at a CAGR of 63.3% during 2016 to 2022, in the moderate growth scenario. Smart inhalers are also known as connected inhalers and sensors and are mainly used as clip-on sensors, which are attached over a normal inhaler (DPIs, MDIs) or nebulizers for the treatment of asthma and COPD. Smart inhalers as defined in this report are defined as devices providing data wirelessly through cloud, internet, or mobile apps. They track the usage of the dose as and when taken by the patients and also alert the patients through timely reminders. Under the scope of study, the report only considers devices that provides data digitally and excludes devices such as traditional inhalers or which do not use smart inhalers. In addition, these devices are available for commercial use as well as used for research and development are considered in the report.

The global smart inhalers market is segmented under three different scenarios: moderate growth scenario, rapid growth scenario, and diminishing growth scenario.

Market growth is attributed to the increase in air pollution, incidence of respiratory diseases such as asthma and COPD, and healthcare burden, due to higher cases of asthma and COPD. In addition, probable increase in adherence to smart inhalers is an additional factor for the growth. However, high cost of asthma and COPD treatment, limited availability of smart inhalers, and misuse of data are expected to restrain the market growth.

Smart Inhalers Market

Top Investment Pockets:

The smart inhalers industry is based on three different scenarios, and therefore top investment pockets have been mentioned with respect to the moderate growth scenario.

North America accounted for the maximum revenue due to wider availability of smart inhalers coupled with wider government initiatives, growth in demand for advanced technology, and increase in use of mobile phones. These devices directly transfer data related to the medications to the mobile app as well as to the cloud server through the internet. Therefore, higher use of mobile phones coupled with rise in cases of asthma and COPD in this region act as major growth opportunities for the market growth.

Regional and Country Overview:

Europe has emerged as the second preferred market for smart inhaler products. Novartis, AstraZeneca, and Boehringer Ingelheim are key players the European region. Adoption of these inhalers, by hospitals and patients boosts the market growth. Moreover, the European Academy of Allergy & Clinical Immunology is continuously making efforts to increase awareness about asthma and COPD.

In the year 2015, the leading revenue-generating region was North America, whereas Asia-Pacific is projected to grow at a significant CAGR of 65.3% during the forecast period, due to rise in demand for smart inhalers and increase in cases of COPD and asthma. Asia-Pacific is the potential market due to high population base, high disposable incomes, and rise in patient awareness, and increase in prevalence of asthma and COPD.

The Turkish smart inhalers industry was valued at $30 thousand in 2015, and is expected to reach $1,090 thousand by 2022, with a CAGR of 65.3% during the forecast period.

Key Players in the Smart Inhalers Market:

Adherium is the key market player with majority product approvals. However, smart inhalers being a lucrative market, acquisitions & collaborations between the pharmaceutical companies, medical device companies, and manufacturers are increasing to capture market space. Increase in collaborations between pharmaceutical companies and manufacturers, such as collaboration between Adherium & AstraZeneca; and GSK partnering with Propeller Health, have led competition in the industry. Major players have adopted product approval and clinical trials as their key development strategies. Important players operating in this market include Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations), Vectura Group plc., Boehringer Ingelheim GmbH, AstraZeneca plc, Cohero Health, LLC; Propeller Health, OPKO Health, Inc. (Inspiro Medical Ltd.), Adherium Limited, Novartis AG, and GlaxoSmithKline plc.

Key Benefits

  • Competitive landscape section includes major players operating within the smart inhalers market, with key strategies adopted by them to achieve high monetary value.
  • The report also provides quantitative as well as qualitative trends to assist the stakeholders to understand the situations prevailing in the market.
  • Entire projections presented in the report are based on analysis of the current trends and highlight the market potential from 2016 to 2022, both in terms of value and volume.
  • The report provides an in-depth analysis of the estimated revenues generated by smart inhalers as well as major geographies during the forecast period.

Smart Inhalers Market Key Segments:

By Product

  • Inhalers
    • Dry Powder Inhalers (DPIs)
    • Metered Dose Inhalers (MDIs)
  • Nebulizers

By Indication

  • Asthma
  • COPD

By End User

  • Patients
  • R&D

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of LAMEA

 

 

Chapter: 1 INTRODUCTION

1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology

1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Analyst Tools and Models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO Perspective

Chapter: 3 MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Key Findings

3.2.1 Top Winning Strategies
3.2.2 Top Investment Pockets

3.3 Porter’s Five Forces Analysis

3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of Substitutes
3.3.4 Threat of New Entrants
3.3.5 Intensity of Competitive Rivalry

3.4 Top Player Positioning, 2015
3.5 Clinical Trials
3.6 Product Portfolio
3.7 Market Dynamics

3.7.1 Drivers

3.7.1.1 Global increase in air pollution
3.7.1.2 Increase in population susceptible to indoor air pollutants
3.7.1.3 Increasing prevalence of COPD and asthma globally
3.7.1.4 Expected increase in adherence to smart inhalers
3.7.1.5 Increasing collaboration between pharmaceutical companies and smart inhaler manufacturers
3.7.1.6 Rising incidences of chronic conditions

3.7.2 Restraints

3.7.2.1 Misusing data and data privacy
3.7.2.2 Availability of smart inhalers
3.7.2.3 Overall high cost of asthma and COPD treatment
3.7.2.4 Resistance towards adoption of smart inhalers

3.7.3 Opportunities

3.7.3.1 Increased focus towards advanced treatment protocols
3.7.3.2 Significant unmet need in respiratory care
3.7.3.3 Increased awareness to reduce healthcare costs
3.7.3.4 Opportunities in emerging economies

Chapter: 4 SMART INHALERS MARKET, BY PRODUCT, 2014-2022

4.1 Overview

4.1.1 Market Size and Forecast

4.2 Inhalers

4.2.1 Key Market Trends
4.2.2 Growth Factors and Opportunities
4.2.3 Market Size and Forecast
4.2.4 Dry Powder Inhalers (DPIs)
4.2.5 Metered Dose Inhalers (MDIs)

4.3 Nebulizers

4.3.1 Key Market Trends
4.3.2 Growth Factors and Opportunities
4.3.3 Market Size and Forecast

Chapter: 5 SMART INHALERS MARKET, BY INDICATION, 2014-2022

5.1 Overview

5.1.1 Market Size and Forecast

5.2 Asthma

5.2.1 Market Size and Forecast

5.3 COPD

5.3.1 Market Size and Forecast

Chapter: 6 SMART INHALERS MARKET, BY END USER, 2014-2022

6.1 Overview

6.1.1 Market Size and Forecast

6.2 Patients

6.2.1 Market Size and Forecast

6.3 R&D

6.3.1 Market Size and Forecast

Chapter: 7 SMART INHALERS MARKET, BY GEOGRAPHY, 2014-2022

7.1 Overview

7.1.1 Market Size and Forecast

7.2 North America

7.2.1 Key Market Trends
7.2.2 Growth Factors and Opportunities
7.2.3 Market Size and Forecast

7.2.3.1 U.S.: Market Size and Forecast
7.2.3.2 Canada: Market Size and Forecast
7.2.3.3 Mexico: Market Size and Forecast

7.3 Europe

7.3.1 Key Market Trends
7.3.2 Growth Factors and Opportunities
7.3.3 Market Size and Forecast

7.3.3.1 Germany: Market Size and Forecast
7.3.3.2 UK: Market Size and Forecast
7.3.3.3 France: Market Size and Forecast
7.3.3.4 Italy: Market Size and Forecast
7.3.3.5 Russia: Market Size and Forecast
7.3.3.6 Rest of Europe: Market Size and Forecast

7.4 Asia-Pacific

7.4.1 Key Market Trends
7.4.2 Growth Factors and Opportunities
7.4.3 Market Size and Forecast

7.4.3.1 Japan: Market Size and Forecast
7.4.3.2 China: Market Size and Forecast
7.4.3.3 India: Market Size and Forecast
7.4.3.4 Australia: Market Size and Forecast
7.4.3.5 Rest of Asia-Pacific: Market Size and Forecast

7.5 LAMEA (Latin America, Middle East, and Africa)

7.5.1 Key Market Trends
7.5.2 Growth Factors and Opportunities
7.5.3 Market Size and Forecast

7.5.3.1 Brazil: Market Size and Forecast
7.5.3.2 Turkey: Market Size and Forecast
7.5.3.3 Saudi Arabia: Market Size and Forecast
7.5.3.4 UAE: Market Size and Forecast
7.5.3.5 Rest of Lamea: Market Size and Forecast

Chapter: 8 COMPANY PROFILES

8.1 Adherium Limited

8.1.1 Company Overview
8.1.2 Company Snapshot
8.1.3 Operating Business Segments
8.1.4 Business Performance
8.1.5 Key Strategic Moves and Developments

8.2 Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations)

8.2.1 Company Overview
8.2.2 Company Snapshot
8.2.3 Operating Business Segments
8.2.4 Business Performance
8.2.5 Key Strategic Moves and Developments

8.3 Propeller Health

8.3.1 Company Overview
8.3.2 Company Snapshot
8.3.3 Operating Business Segments
8.3.4 Business Performance
8.3.5 Key Strategic Moves and Developments

8.4 Cohero Health, LLC

8.4.1 Company Overview
8.4.2 Company Snapshot
8.4.3 Operating Business Segments
8.4.4 Business Performance
8.4.5 Key Strategic Moves and Developments

8.5 OPKO Health, Inc. (Inspiro Medical Ltd.)

8.5.1 Company Overview
8.5.2 Company Snapshot
8.5.3 Operating Business Segments
8.5.4 Business Performance
8.5.5 Key Strategic Moves and Developments

8.6 GlaxoSmithKline plc

8.6.1 Company Overview
8.6.2 Operating Business Segments
8.6.3 Business Performance
8.6.4 Key Strategic Moves and Developments

8.7 Novartis AG

8.7.1 Company Overview
8.7.2 Operating Business Segments
8.7.3 Business Performance
8.7.4 Key Strategic Moves and Developments

8.8 AstraZeneca plc

8.8.1 Company Overview
8.8.2 Operating Business Segments
8.8.3 Business Performance
8.8.4 Key Strategic Moves and Developments

8.9 Boehringer Ingelheim GmbH

8.9.1 Company Overview
8.9.2 Operating Business Segments
8.9.3 Business Performance
8.9.4 Key Strategic Moves and Developments

8.10 Vectura Group plc

8.10.1 Company Overview
8.10.2 Company Snapshot
8.10.3 Operating Business Segments
8.10.4 Business Performance
8.10.5 Key Strategic Moves and Developments

List of Figures

FIG. 1 PRIMARY RESPONDENTS: % SPLIT
FIG. 2 SMART INHALERS MARKET: SEGMENTATION
FIG. 3 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION
FIG. 4 TOP WINNING STRATEGIES: NATURE & TYPE
FIG. 5 TYPES OF STRATEGIES DISTRIBUTION
FIG. 6 DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIG. 7 DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIG. 8 TOP INVESTMENT POCKETS: WORLD SMART INHALERS, BY REGION
FIG. 9 PORTER’S FIVE FORCES ANALYSIS
FIG. 10 TOP PLAYER POSITIONING, 2015
FIG. 11 TOP IMPACTING FACTORS: SMART INHALERS MARKET, 2015-2022
FIG. 12 ASTHMA: MAJOR INFLUENCING FACTORS
FIG. 13 ASTHMA: ECONOMIC BURDEN
FIG. 14 GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (GOLD) CLASSIFICATION OF COPD
FIG. 15 COPD: MAJOR CAUSES
FIG. 16 U.S.: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 17 U.S.: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 18 CANADA: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 19 CANADA: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 20 MEXICO: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 21 MEXICO: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 22 GERMANY: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 23 GERMANY: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 24 UK: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 25 UK: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 26 FRANCE: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 27 FRANCE: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 28 ITALY: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 29 ITALY: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 30 RUSSIA: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 31 RUSSIA: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 32 REST OF EUROPE: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 33 REST OF EUROPE: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 34 JAPAN: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 35 JAPAN: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 36 CHINA: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 37 CHINA: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 38 INDIA: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 39 INDIA: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 40 AUSTRALIA: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 41 AUSTRALIA: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 42 REST OF ASIA-PACIFIC: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 43 REST OF ASIA-PACIFIC: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 44 BRAZIL: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 45 BRAZIL: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 46 TURKEY: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 47 TURKEY: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 48 SAUDI ARABIA: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 49 SAUDI ARABIA: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 50 UAE: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 51 UAE: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 52 REST OF LAMEA: SMART INHALERS MARKET SIZE, 2014-2022 ($000’)
FIG. 53 REST OF LAMEA: SMART INHALERS MARKET SIZE, 2014-2022 (TOTAL UNITS)
FIG. 54 ADHERIUM: NET REVENUE, 2014-2015 ($MILLION)
FIG. 55 ADHERIUM: STRATEGY SHARE, 2015-2016 (%)
FIG. 56 TEVA: REVENUE, 2013-2015 ($MILLION)
FIG. 57 TEVA: REVENUE, BY PRODUCT TYPE, 2015 (%)
FIG. 58 PROPELLER HEALTH: STRATEGY SHARE, 2015-2016 (%)
FIG. 59 COHERO HEALTH: STRATEGY SHARE, 2014-2016 (%)
FIG. 60 OPKO HEALTH: REVENUE, 2013-2015 ($MILLION)
FIG. 61 OPKO HEALTH: REVENUE, BY SEGMENT, 2015 (%)
FIG. 62 OPKO HEALTH: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 63 OPKO HEALTH: STRATEGY SHARE, 2013-2014 (%)
FIG. 64 GSK: REVENUE, 2013-2015 ($MILLION)
FIG. 65 GSK: REVENUE, BY SEGMENT, 2015 (%)
FIG. 66 GSK: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 67 GSK: STRATEGY SHARE, 2013-2015 (%)
FIG. 68 NOVARTIS: REVENUE, 2013-2015 ($MILLION)
FIG. 69 NOVARTIS: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 70 NOVARTIS: REVENUE, BY SEGMENT, 2015 (%)
FIG. 71 NOVARTIS: STRATEGY SHARE, 2013-2015 (%)
FIG. 72 ASTRAZENECA: REVENUE, 2013-2015 ($MILLION)
FIG. 73 ASTRAZENECA: REVENUE, BY SEGMENT, 2015 (%)
FIG. 74 ASTRAZENECA: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 75 ASTRAZENECA: STRATEGY SHARE, 2014-2016 (%)
FIG. 76 BOEHRINGER INGELHEIM: REVENUE, 2013-2015 ($MILLION)
FIG. 77 BOEHRINGER INGELHEIM: REVENUE, BY SEGMENT, 2015 (%)
FIG. 78 BOEHRINGER INGELHEIM: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 79 BOEHRINGER INGELHEIM: STRATEGY SHARE, 2014-2016 (%)
FIG. 80 VECTURA: REVENUE, 2013-2015 ($MILLION)
FIG. 81 VECTURA: REVENUE, BY GEOGRAPHY, 2015 (%)

List of Tables

TABLE 1 CLINICAL TRIALS: SMART INHALERS
TABLE 2 SMART INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 3 SMART INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 4 SMART INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), RAPID SCENARIO
TABLE 5 SMART INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 6 SMART INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 7 SMART INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 8 INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 9 INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 10 INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), RAPID SCENARIO
TABLE 11 INHALERS MARKET, BY GEOGRAPHY, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 12 INHALERS MARKET, BY GEOGRAPHY, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 13 INHALERS MARKET, BY GEOGRAPHY, 2014-2022 ($000’), RAPID SCENARIO
TABLE 14 INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 15 INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 16 INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 17 INHALERS MARKET, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 18 INHALERS MARKET, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 19 INHALERS MARKET, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 20 DPIS: TYPES
TABLE 21 NEBULIZERS MARKET, BY GEOGRAPHY, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 22 NEBULIZERS MARKET, BY GEOGRAPHY, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 23 NEBULIZERS MARKET, BY GEOGRAPHY, 2014-2022 ($000’), RAPID SCENARIO
TABLE 24 NEBULIZERS MARKET, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 25 NEBULIZERS MARKET, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 26 NEBULIZERS MARKET, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 27 SMART INHALERS MARKET, BY INDICATION, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 28 SMART INHALERS MARKET, BY INDICATION, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 29 SMART INHALERS MARKET, BY INDICATION, 2014-2022 ($000’), RAPID SCENARIO
TABLE 30 SMART INHALERS MARKET, BY INDICATION, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 31 SMART INHALERS MARKET, BY INDICATION, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 32 SMART INHALERS MARKET, BY INDICATION, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 33 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 34 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 35 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 2014-2022 ($000’), RAPID SCENARIO
TABLE 36 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 37 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 38 SMART INHALERS MARKET FOR ASTHMA, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 39 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 40 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 41 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 2014-2022 ($000’), RAPID SCENARIO
TABLE 42 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 43 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 44 SMART INHALERS MARKET FOR COPD, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 45 SMART INHALERS MARKET, BY END USER, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 46 SMART INHALERS MARKET, BY END USER, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 47 SMART INHALERS MARKET, BY END USER, 2014-2022 ($000’), RAPID SCENARIO
TABLE 48 SMART INHALERS MARKET, BY END USER, 2014-2022 (TOTAL UNITS’), MODERATE SCENARIO
TABLE 49 SMART INHALERS MARKET, BY END USER, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 50 SMART INHALERS MARKET, BY END USER, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 51 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 52 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 53 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 2014-2022 ($000’), RAPID SCENARIO
TABLE 54 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 55 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 56 SMART INHALERS MARKET FOR PATIENTS, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS’), RAPID SCENARIO
TABLE 57 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 58 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 59 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 2014-2022 ($000’), RAPID SCENARIO
TABLE 60 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 61 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 62 SMART INHALERS MARKET FOR R&D, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 63 SMART INHALERS MARKET, BY GEOGRAPHY, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 64 SMART INHALERS MARKET, BY GEOGRAPHY, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 65 SMART INHALERS MARKET, BY GEOGRAPHY, 2014-2022 ($000’), RAPID SCENARIO
TABLE 66 SMART INHALERS MARKET, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 67 SMART INHALERS MARKET, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 68 SMART INHALERS MARKET, BY GEOGRAPHY, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 69 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 70 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 71 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 2014-2022 ($000’), RAPID SCENARIO
TABLE 72 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 73 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 74 NORTH AMERICA: SMART INHALERS MARKET, BY INDICATION, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 75 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 76 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 77 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 2014-2022 ($000’), RAPID SCENARIO
TABLE 78 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 79 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 80 NORTH AMERICA: SMART INHALERS MARKET, BY END USER, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 81 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 82 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 83 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), RAPID SCENARIO
TABLE 84 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 85 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 86 NORTH AMERICA: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 87 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 88 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 89 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 ($000’), RAPID SCENARIO
TABLE 90 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 91 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 92 NORTH AMERICA: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 93 EUROPE: SMART INHALERS MARKET, BY INDICATION, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 94 EUROPE: SMART INHALERS MARKET, BY INDICATION, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 95 EUROPE: SMART INHALERS MARKET, BY INDICATION, 2014-2022 ($000’), RAPID SCENARIO
TABLE 96 EUROPE: SMART INHALERS MARKET, BY INDICATION, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 97 EUROPE: SMART INHALERS MARKET, BY INDICATION, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 98 EUROPE: SMART INHALERS MARKET, BY INDICATION, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 99 EUROPE: SMART INHALERS MARKET, BY END USER, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 100 EUROPE: SMART INHALERS MARKET, BY END USER, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 101 EUROPE: SMART INHALERS MARKET, BY END USER, 2014-2022 ($000’), RAPID SCENARIO
TABLE 102 EUROPE: SMART INHALERS MARKET, BY END USER, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 103 EUROPE: SMART INHALERS MARKET, BY END USER, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 104 EUROPE: SMART INHALERS MARKET, BY END USER, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 105 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 106 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 107 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), RAPID SCENARIO
TABLE 108 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 109 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 110 EUROPE: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 111 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 112 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 113 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 ($000’), RAPID SCENARIO
TABLE 114 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 115 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 116 EUROPE: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 117 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 118 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 119 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 2014-2022 ($000’), RAPID SCENARIO
TABLE 120 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 121 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 122 ASIA-PACIFIC: SMART INHALERS MARKET, BY INDICATION, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 123 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 124 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 125 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 2014-2022 ($000’), RAPID SCENARIO
TABLE 126 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 127 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 128 ASIA-PACIFIC: SMART INHALERS MARKET, BY END USER, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 129 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 130 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 131 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), RAPID SCENARIO
TABLE 132 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 133 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 134 ASIA-PACIFIC: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 135 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 136 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 137 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 ($000’), RAPID SCENARIO
TABLE 138 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 139 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 140 ASIA-PACIFIC: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 141 LAMEA: SMART INHALERS MARKET, BY INDICATION, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 142 LAMEA: SMART INHALERS MARKET, BY INDICATION, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 143 LAMEA: SMART INHALERS MARKET, BY INDICATION, 2014-2022 ($000’), RAPID SCENARIO
TABLE 144 LAMEA: SMART INHALERS MARKET, BY INDICATION, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 145 LAMEA: SMART INHALERS MARKET, BY INDICATION, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 146 LAMEA: SMART INHALERS MARKET, BY INDICATION, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 147 LAMEA: SMART INHALERS MARKET, BY END USER, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 148 LAMEA: SMART INHALERS MARKET, BY END USER, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 149 LAMEA: SMART INHALERS MARKET, BY END USER, 2014-2022 ($000’), RAPID SCENARIO
TABLE 150 LAMEA: SMART INHALERS MARKET, BY END USER, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 151 LAMEA: SMART INHALERS MARKET, BY END USER, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 152 LAMEA: SMART INHALERS MARKET, BY END USER, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 153 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 154 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 155 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 ($000’), RAPID SCENARIO
TABLE 156 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 157 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 158 LAMEA: SMART INHALERS MARKET, BY PRODUCT, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 159 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 ($000’), MODERATE SCENARIO
TABLE 160 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 ($000’), DIMINISHING SCENARIO
TABLE 161 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 ($000’), RAPID SCENARIO
TABLE 162 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 (TOTAL UNITS), MODERATE SCENARIO
TABLE 163 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 (TOTAL UNITS), DIMINISHING SCENARIO
TABLE 164 LAMEA: SMART INHALERS MARKET, BY COUNTRY, 2014-2022 (TOTAL UNITS), RAPID SCENARIO
TABLE 165 ADHERIUM: COMPANY SNAPSHOT
TABLE 166 ADHERIUM: OPERATING SEGMENTS
TABLE 167 TEVA: COMPANY SNAPSHOT
TABLE 168 TEVA: OPERATING SEGMENTS
TABLE 169 PROPELLER HEALTH: COMPANY SNAPSHOT
TABLE 170 PROPELLER HEALTH: OPERATING SEGMENTS
TABLE 171 COHERO HEALTH: COMPANY SNAPSHOT
TABLE 172 COHERO HEALTH: OPERATING SEGMENTS
TABLE 173 OPKO HEALTH: COMPANY SNAPSHOT
TABLE 174 OPKO HEALTH: OPERATING SEGMENTS
TABLE 175 GSK: COMPANY SNAPSHOT
TABLE 176 GSK: OPERATING SEGMENTS
TABLE 177 NOVARTIS: COMPANY SNAPSHOT
TABLE 178 NOVARTIS: OPERATING SEGMENTS
TABLE 179 ASTRAZENECA: COMPANY SNAPSHOT
TABLE 180 ASTRAZENECA: OPERATING SEGMENTS
TABLE 181 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 182 BOEHRINGER INGELHEIM: OPERATING SEMENTS
TABLE 183 VECTURA: COMPANY SNAPSHOT
TABLE 184 VECTURA: OPERATING SEGMENTS

 

Asthma and COPD have posed a burden for healthcare organizations and government authorities due to the spiraling increase in their incidence and prevalence rates in the world. In 2015, approximately 235 million people across the globe were diagnosed with asthma. As per the WHO, COPD caused approximately 3 million reported deaths in 2012, and is expected to be the third leading cause of death by 2030.

Technological advancements in the field of respiratory management have taken place in the recent years. One such event is the advent of smart inhalers. Smart inhaler is an emerging technology that is used for the treatment and better disease management of asthma and COPD. Presently, only traditional inhalers are used for management of respiratory diseases. However, introduction of smart inhalers give an added advantage over traditional inhalers, as they facilitate direct connectivity to cloud through internet and enable data transfer for use by doctors.

Most of the devices are in the clinical trial phase. Adherium Limited is a key player in the smart inhalers market. Numerous clinical trial studies conducted by Adherium showed that the adherence rate to smart inhalers increased by 180% and 59% in children and adults, respectively. Smart inhalers can be used as an inhaler as well as a nebulizer. Inhalers segment is expected to occupy the maximum share of the global market in the near future.

Majority of smart inhalers are currently used in the clinical trial phase, while only limited number of products are available in the market for commercial purposes. The launch of advanced products with effective monitoring features and therapeutic outcomes is expected to boost the market growth.

North American region is projected to dominate the global market due to better management and widespread availability of smart inhalers. Furthermore, high incidence of asthma and COPD and increase in mortality due to COPD is expected to drive the growth of the U.S. market.

The market is expected to grow significantly due to data compilation for asthma and COPD patients to keep a track of their medicines for patient monitoring analysis. Furthermore, improved adherence of inhalers is expected to significantly decrease healthcare costs and increase the uptake of smart inhalers in the near future.

 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 

Get More Information About This Report

For any queries about purchasing this report, For any queries, please fill the form below:

Please input the above text in the input box or click refresh

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASK
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Readings

 
 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts